Topic: Sammy Saab
Treating prisoners in the United States who have hepatitis C with standard pegylated-interferon and ribavirin therapy would be cost-effective, according to research published online July 16 in Hepatology.. Sammy Saab, M.D., of the University of California, Los Angeles, and colleagues created ...
